A large trial suggests a simple blood test could catch several cancers years earlier than current methods.
The results, presented at a major conference, are preliminary but striking, hinting at a future where routine screening catches disease long before symptoms appear.
Researchers caution that questions remain about false positives and cost, the twin obstacles that have sunk promising tests before.
From detection to prevention
Still, the direction of travel is clear, and the excitement among clinicians is real.
"Catching it early is the difference between a scare and a tragedy."
Analysts point to a handful of forces driving the story forward:
- A single blood draw screening for multiple cancers
- Earlier detection windows for aggressive types
- Open questions on accuracy and access
Wider trials are already being planned, with the first real-world programmes potentially years away.